Share Price and Basic Stock Data
Last Updated: November 5, 2025, 6:13 pm
| PEG Ratio | -13.85 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Anupam Rasayan India Ltd operates within the specialty chemicals sector, focusing on a range of products that cater to various industries. The company reported total sales of ₹1,602 Cr for the financial year ending March 2023, reflecting a significant growth trajectory compared to ₹1,074 Cr in March 2022. However, sales for the subsequent year (March 2024) declined to ₹1,475 Cr and further to ₹1,437 Cr for March 2025, indicating a contraction in revenue generation. On a quarterly basis, sales fluctuated, with the highest quarterly revenue recorded at ₹480 Cr in March 2023 and a notable dip to ₹296 Cr in December 2023, before rebounding to ₹401 Cr in March 2024. The trailing twelve months (TTM) sales stood at ₹1,670 Cr, showcasing a resilient performance despite recent fluctuations. This indicates that while Anupam Rasayan has experienced substantial growth, it faces challenges in maintaining consistent revenue levels in the face of market dynamics.
Profitability and Efficiency Metrics
Anupam Rasayan’s profitability metrics reveal a mixed performance over the recent financial periods. The net profit for the financial year ending March 2023 was ₹217 Cr, which decreased to ₹167 Cr in March 2024 and further to ₹160 Cr in March 2025. The operating profit margin (OPM) for March 2025 stood at 28.69%, slightly above the previous year’s 27.85%, indicating some operational efficiency. However, the return on equity (ROE) was low at 3.32%, and return on capital employed (ROCE) further declined to 7.33% in March 2025, suggesting challenges in generating returns from the capital invested. The company’s interest coverage ratio (ICR) was reported at 3.67x, indicating that earnings are sufficient to cover interest expenses, which is a positive sign. However, the cash conversion cycle (CCC) of 715 days reflects inefficiencies in managing working capital, highlighting potential areas for operational improvement.
Balance Sheet Strength and Financial Ratios
The balance sheet of Anupam Rasayan exhibits a growing reserve base, which stood at ₹2,740 Cr as of March 2025, a substantial increase from ₹1,627 Cr in March 2022. However, the company’s borrowings rose to ₹1,373 Cr, up from ₹822 Cr in March 2023, indicating an increased reliance on debt to finance its operations. The total liabilities reached ₹5,269 Cr, while total assets amounted to ₹5,269 Cr, showcasing a balanced approach but raising concerns about leverage. The debt-to-equity ratio was recorded at 0.46, suggesting moderate financial risk. The price-to-book value (P/BV) ratio stood at 2.94x, reflecting a premium valuation compared to typical sector ranges. Additionally, the interest coverage ratio of 3.67x indicates that the company can comfortably meet its interest obligations, which is crucial for maintaining investor confidence.
Shareholding Pattern and Investor Confidence
Anupam Rasayan’s shareholding pattern reveals a significant promoter holding of 59.07% as of July 2025, indicating a strong commitment from the company’s founders. However, foreign institutional investors (FIIs) have shown a declining trend, reducing their stake to 7.76% from a peak of 10.26% in September 2023. Domestic institutional investors (DIIs) also recorded a decrease in holding to 2.11%. The public shareholding has increased slightly to 31.05%, which may indicate growing retail investor interest. The number of shareholders has seen a decline to 48,524, suggesting potential concerns regarding investor confidence. The shift in shareholding dynamics, particularly the drop in institutional investments, could pose risks to the stock’s liquidity and overall market perception, necessitating strategies to enhance investor relations and restore confidence.
Outlook, Risks, and Final Insight
Looking ahead, Anupam Rasayan faces a mix of opportunities and challenges. The company’s strong reserve position and sufficient liquidity may provide a buffer against market volatility. However, the fluctuating sales and declining profitability metrics present significant risks. The high cash conversion cycle and low ROE indicate areas for operational enhancement. The company must focus on improving efficiency and managing working capital effectively to sustain growth. Additionally, the declining interest from institutional investors may impact market perception and stock performance. Anupam Rasayan should leverage its strong promoter backing to instill confidence among institutional investors while addressing operational inefficiencies. In scenarios where management can effectively streamline operations and enhance profitability, the company could regain momentum; otherwise, it may face continued pressure in a competitive market environment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Anupam Rasayan India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 465 Cr. | 50.6 | 86.7/42.6 | 28.3 | 20.0 | 0.79 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 37.7 Cr. | 76.8 | 103/56.0 | 16.8 | 87.4 | 1.30 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 48.7 Cr. | 717 | 1,140/600 | 53.0 | 670 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,797 Cr. | 83.7 | 114/78.0 | 25.3 | 20.7 | 0.60 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 754 Cr. | 302 | 453/241 | 27.0 | 91.1 | 0.83 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,756.00 Cr | 731.20 | 47.78 | 178.98 | 0.41% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 344 | 393 | 392 | 480 | 386 | 392 | 296 | 401 | 254 | 294 | 390 | 500 | 486 |
| Expenses | 245 | 282 | 281 | 363 | 285 | 285 | 216 | 308 | 201 | 214 | 266 | 356 | 362 |
| Operating Profit | 99 | 111 | 111 | 117 | 101 | 107 | 79 | 93 | 53 | 80 | 124 | 144 | 124 |
| OPM % | 29% | 28% | 28% | 24% | 26% | 27% | 27% | 23% | 21% | 27% | 32% | 29% | 26% |
| Other Income | -8 | -10 | -3 | 24 | 12 | 3 | 2 | 12 | 6 | 2 | -4 | 6 | 5 |
| Interest | 12 | 16 | 14 | 20 | 18 | 20 | 25 | 26 | 22 | 27 | 32 | 31 | 36 |
| Depreciation | 16 | 18 | 18 | 19 | 19 | 20 | 20 | 21 | 21 | 22 | 29 | 31 | 31 |
| Profit before tax | 62 | 67 | 75 | 103 | 77 | 71 | 36 | 58 | 16 | 34 | 59 | 88 | 63 |
| Tax % | 32% | 29% | 28% | 29% | 32% | 31% | 28% | 30% | 25% | 10% | 9% | 29% | 23% |
| Net Profit | 42 | 48 | 54 | 73 | 52 | 49 | 26 | 40 | 12 | 31 | 54 | 63 | 48 |
| EPS in Rs | 3.96 | 4.15 | 4.00 | 5.28 | 3.59 | 3.78 | 1.68 | 2.82 | 0.36 | 1.52 | 2.56 | 4.05 | 3.10 |
Last Updated: August 19, 2025, 11:40 pm
Below is a detailed analysis of the quarterly data for Anupam Rasayan India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 486.00 Cr.. The value appears to be declining and may need further review. It has decreased from 500.00 Cr. (Mar 2025) to 486.00 Cr., marking a decrease of 14.00 Cr..
- For Expenses, as of Jun 2025, the value is 362.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 356.00 Cr. (Mar 2025) to 362.00 Cr., marking an increase of 6.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 144.00 Cr. (Mar 2025) to 124.00 Cr., marking a decrease of 20.00 Cr..
- For OPM %, as of Jun 2025, the value is 26.00%. The value appears to be declining and may need further review. It has decreased from 29.00% (Mar 2025) to 26.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 36.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 5.00 Cr..
- For Depreciation, as of Jun 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 31.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 88.00 Cr. (Mar 2025) to 63.00 Cr., marking a decrease of 25.00 Cr..
- For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Mar 2025) to 23.00%, marking a decrease of 6.00%.
- For Net Profit, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 15.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.10. The value appears to be declining and may need further review. It has decreased from 4.05 (Mar 2025) to 3.10, marking a decrease of 0.95.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:56 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 502 | 529 | 811 | 1,074 | 1,602 | 1,475 | 1,437 | 1,670 |
| Expenses | 408 | 394 | 617 | 769 | 1,171 | 1,094 | 1,036 | 1,197 |
| Operating Profit | 93 | 135 | 194 | 305 | 431 | 381 | 401 | 473 |
| OPM % | 19% | 25% | 24% | 28% | 27% | 26% | 28% | 28% |
| Other Income | 19 | 11 | 26 | 8 | 10 | 30 | 11 | 9 |
| Interest | 24 | 45 | 69 | 31 | 63 | 89 | 112 | 126 |
| Depreciation | 23 | 29 | 52 | 60 | 71 | 80 | 102 | 112 |
| Profit before tax | 66 | 72 | 100 | 222 | 308 | 242 | 198 | 244 |
| Tax % | 24% | 26% | 30% | 31% | 30% | 31% | 19% | |
| Net Profit | 49 | 53 | 70 | 152 | 217 | 167 | 160 | 196 |
| EPS in Rs | 9.85 | 10.64 | 7.04 | 15.18 | 16.84 | 11.72 | 8.49 | 11.23 |
| Dividend Payout % | -0% | -0% | 7% | 7% | 15% | 11% | 9% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 8.16% | 32.08% | 117.14% | 42.76% | -23.04% | -4.19% |
| Change in YoY Net Profit Growth (%) | 0.00% | 23.91% | 85.07% | -74.38% | -65.80% | 18.85% |
Anupam Rasayan India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 10% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | -15% |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 13% |
| 1 Year: | 44% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 5% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: September 10, 2025, 3:02 pm
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 50 | 50 | 100 | 100 | 107 | 110 | 110 |
| Reserves | 432 | 515 | 1,473 | 1,627 | 2,265 | 2,651 | 2,740 |
| Borrowings | 694 | 847 | 423 | 836 | 822 | 1,069 | 1,373 |
| Other Liabilities | 146 | 252 | 301 | 327 | 584 | 772 | 1,045 |
| Total Liabilities | 1,323 | 1,664 | 2,298 | 2,891 | 3,778 | 4,602 | 5,269 |
| Fixed Assets | 681 | 977 | 1,115 | 1,202 | 1,417 | 1,501 | 2,185 |
| CWIP | 191 | 101 | 43 | 44 | 120 | 609 | 216 |
| Investments | 0 | 0 | 0 | 149 | 67 | 67 | 9 |
| Other Assets | 451 | 586 | 1,140 | 1,496 | 2,173 | 2,424 | 2,860 |
| Total Assets | 1,323 | 1,664 | 2,298 | 2,891 | 3,778 | 4,602 | 5,269 |
Below is a detailed analysis of the balance sheet data for Anupam Rasayan India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 110.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 110.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,740.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,651.00 Cr. (Mar 2024) to 2,740.00 Cr., marking an increase of 89.00 Cr..
- For Borrowings, as of Mar 2025, the value is 1,373.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,069.00 Cr. (Mar 2024) to 1,373.00 Cr., marking an increase of 304.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1,045.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 772.00 Cr. (Mar 2024) to 1,045.00 Cr., marking an increase of 273.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 5,269.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,602.00 Cr. (Mar 2024) to 5,269.00 Cr., marking an increase of 667.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2,185.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,501.00 Cr. (Mar 2024) to 2,185.00 Cr., marking an increase of 684.00 Cr..
- For CWIP, as of Mar 2025, the value is 216.00 Cr.. The value appears to be declining and may need further review. It has decreased from 609.00 Cr. (Mar 2024) to 216.00 Cr., marking a decrease of 393.00 Cr..
- For Investments, as of Mar 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Mar 2024) to 9.00 Cr., marking a decrease of 58.00 Cr..
- For Other Assets, as of Mar 2025, the value is 2,860.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,424.00 Cr. (Mar 2024) to 2,860.00 Cr., marking an increase of 436.00 Cr..
- For Total Assets, as of Mar 2025, the value is 5,269.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,602.00 Cr. (Mar 2024) to 5,269.00 Cr., marking an increase of 667.00 Cr..
Notably, the Reserves (2,740.00 Cr.) exceed the Borrowings (1,373.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -601.00 | -712.00 | -229.00 | -531.00 | -391.00 | 380.00 | 400.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 88 | 89 | 92 | 95 | 95 | 143 | 186 |
| Inventory Days | 277 | 515 | 530 | 852 | 483 | 627 | 876 |
| Days Payable | 105 | 226 | 215 | 225 | 167 | 247 | 348 |
| Cash Conversion Cycle | 260 | 379 | 408 | 722 | 410 | 524 | 715 |
| Working Capital Days | 56 | 21 | 168 | 218 | 153 | 138 | 160 |
| ROCE % | 9% | 10% | 11% | 13% | 9% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Quant Small Cap Fund | 2,086,516 | 1.26 | 198.07 | 2,086,516 | 2025-04-22 17:25:14 | 0% |
| Aditya Birla Sun Life Pure Value Fund | 321,844 | 0.54 | 30.55 | 321,844 | 2025-04-22 17:25:14 | 0% |
| Nippon India Nifty Smallcap 250 Index Fund | 16,067 | 0.14 | 1.53 | 16,067 | 2025-04-22 17:25:14 | 0% |
| Axis Nifty Smallcap 50 Index Fund | 11,015 | 0.43 | 1.05 | 11,015 | 2025-04-22 17:25:14 | 0% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 9,823 | 0.14 | 0.93 | 9,823 | 2025-04-22 17:25:14 | 0% |
| Aditya Birla Sun Life Nifty Smallcap 50 Index Fund | 8,754 | 0.44 | 0.83 | 8,754 | 2025-04-22 17:25:14 | 0% |
| SBI Nifty Smallcap 250 Index Fund | 8,158 | 0.14 | 0.77 | 8,158 | 2025-04-22 17:25:14 | 0% |
| ICICI Prudential Nifty Smallcap 250 Index Fund | 3,725 | 0.14 | 0.35 | 3,725 | 2025-04-22 17:25:14 | 0% |
| Motilal Oswal Nifty 500 Index Fund | 972 | 0.01 | 0.09 | 972 | 2025-04-22 17:25:14 | 0% |
| Edelweiss Nifty Smallcap 250 Index Fund | 442 | 0.14 | 0.04 | 442 | 2025-04-22 17:25:14 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.50 | 15.48 | 20.91 | 15.22 | 8.56 |
| Diluted EPS (Rs.) | 8.50 | 15.46 | 20.86 | 15.18 | 8.56 |
| Cash EPS (Rs.) | 23.86 | 22.51 | 26.66 | 21.11 | 12.20 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 259.28 | 251.49 | 233.38 | 172.26 | 157.46 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 259.28 | 251.49 | 233.38 | 172.26 | 157.46 |
| Revenue From Operations / Share (Rs.) | 130.72 | 134.36 | 149.06 | 106.34 | 81.15 |
| PBDIT / Share (Rs.) | 37.51 | 37.43 | 40.94 | 31.14 | 22.04 |
| PBIT / Share (Rs.) | 28.20 | 30.17 | 34.32 | 25.14 | 16.87 |
| PBT / Share (Rs.) | 18.00 | 22.02 | 28.49 | 22.07 | 10.01 |
| Net Profit / Share (Rs.) | 14.55 | 15.25 | 20.04 | 15.12 | 7.04 |
| NP After MI And SOA / Share (Rs.) | 8.49 | 11.71 | 16.83 | 15.18 | 7.04 |
| PBDIT Margin (%) | 28.69 | 27.85 | 27.46 | 29.28 | 27.15 |
| PBIT Margin (%) | 21.57 | 22.45 | 23.02 | 23.64 | 20.78 |
| PBT Margin (%) | 13.76 | 16.39 | 19.11 | 20.75 | 12.33 |
| Net Profit Margin (%) | 11.13 | 11.35 | 13.44 | 14.21 | 8.66 |
| NP After MI And SOA Margin (%) | 6.49 | 8.71 | 11.28 | 14.27 | 8.66 |
| Return on Networth / Equity (%) | 3.27 | 4.65 | 7.62 | 8.81 | 4.46 |
| Return on Capital Employeed (%) | 8.95 | 10.07 | 12.43 | 10.97 | 8.97 |
| Return On Assets (%) | 1.77 | 2.79 | 4.78 | 5.26 | 3.05 |
| Long Term Debt / Equity (X) | 0.06 | 0.07 | 0.14 | 0.28 | 0.15 |
| Total Debt / Equity (X) | 0.46 | 0.36 | 0.33 | 0.46 | 0.24 |
| Asset Turnover Ratio (%) | 0.29 | 0.35 | 0.48 | 0.41 | 0.40 |
| Current Ratio (X) | 1.42 | 1.69 | 2.60 | 2.43 | 2.59 |
| Quick Ratio (X) | 0.62 | 0.89 | 1.46 | 0.98 | 1.42 |
| Inventory Turnover Ratio (X) | 0.74 | 0.69 | 0.85 | 1.02 | 1.19 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 16.71 | 5.78 | 3.28 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 10.32 | 4.15 | 2.35 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 83.29 | 94.22 | 96.72 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 89.68 | 95.85 | 97.65 | 0.00 |
| Interest Coverage Ratio (X) | 3.67 | 4.59 | 7.02 | 10.13 | 3.21 |
| Interest Coverage Ratio (Post Tax) (X) | 2.43 | 2.87 | 4.44 | 5.92 | 2.03 |
| Enterprise Value (Cr.) | 9804.24 | 10438.77 | 9646.44 | 8830.95 | 4991.83 |
| EV / Net Operating Revenue (X) | 6.82 | 7.08 | 6.02 | 8.28 | 6.16 |
| EV / EBITDA (X) | 23.78 | 25.40 | 21.93 | 28.29 | 22.67 |
| MarketCap / Net Operating Revenue (X) | 5.83 | 6.47 | 5.80 | 7.73 | 6.04 |
| Retention Ratios (%) | 0.00 | 83.28 | 94.21 | 96.71 | 0.00 |
| Price / BV (X) | 2.94 | 3.45 | 3.91 | 4.77 | 3.11 |
| Price / Net Operating Revenue (X) | 5.83 | 6.47 | 5.80 | 7.73 | 6.04 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Anupam Rasayan India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 15.48 (Mar 24) to 8.50, marking a decrease of 6.98.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 15.46 (Mar 24) to 8.50, marking a decrease of 6.96.
- For Cash EPS (Rs.), as of Mar 25, the value is 23.86. This value is within the healthy range. It has increased from 22.51 (Mar 24) to 23.86, marking an increase of 1.35.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 259.28. It has increased from 251.49 (Mar 24) to 259.28, marking an increase of 7.79.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 259.28. It has increased from 251.49 (Mar 24) to 259.28, marking an increase of 7.79.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 130.72. It has decreased from 134.36 (Mar 24) to 130.72, marking a decrease of 3.64.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 37.51. This value is within the healthy range. It has increased from 37.43 (Mar 24) to 37.51, marking an increase of 0.08.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.20. This value is within the healthy range. It has decreased from 30.17 (Mar 24) to 28.20, marking a decrease of 1.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 18.00. This value is within the healthy range. It has decreased from 22.02 (Mar 24) to 18.00, marking a decrease of 4.02.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 15.25 (Mar 24) to 14.55, marking a decrease of 0.70.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.49. This value is within the healthy range. It has decreased from 11.71 (Mar 24) to 8.49, marking a decrease of 3.22.
- For PBDIT Margin (%), as of Mar 25, the value is 28.69. This value is within the healthy range. It has increased from 27.85 (Mar 24) to 28.69, marking an increase of 0.84.
- For PBIT Margin (%), as of Mar 25, the value is 21.57. This value exceeds the healthy maximum of 20. It has decreased from 22.45 (Mar 24) to 21.57, marking a decrease of 0.88.
- For PBT Margin (%), as of Mar 25, the value is 13.76. This value is within the healthy range. It has decreased from 16.39 (Mar 24) to 13.76, marking a decrease of 2.63.
- For Net Profit Margin (%), as of Mar 25, the value is 11.13. This value exceeds the healthy maximum of 10. It has decreased from 11.35 (Mar 24) to 11.13, marking a decrease of 0.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.49. This value is below the healthy minimum of 8. It has decreased from 8.71 (Mar 24) to 6.49, marking a decrease of 2.22.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.27. This value is below the healthy minimum of 15. It has decreased from 4.65 (Mar 24) to 3.27, marking a decrease of 1.38.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.95. This value is below the healthy minimum of 10. It has decreased from 10.07 (Mar 24) to 8.95, marking a decrease of 1.12.
- For Return On Assets (%), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 5. It has decreased from 2.79 (Mar 24) to 1.77, marking a decrease of 1.02.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has increased from 0.36 (Mar 24) to 0.46, marking an increase of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.29. It has decreased from 0.35 (Mar 24) to 0.29, marking a decrease of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 1.5. It has decreased from 1.69 (Mar 24) to 1.42, marking a decrease of 0.27.
- For Quick Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.89 (Mar 24) to 0.62, marking a decrease of 0.27.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 4. It has increased from 0.69 (Mar 24) to 0.74, marking an increase of 0.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 16.71 (Mar 24) to 0.00, marking a decrease of 16.71.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.32 (Mar 24) to 0.00, marking a decrease of 10.32.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 83.29 (Mar 24) to 0.00, marking a decrease of 83.29.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.68 (Mar 24) to 0.00, marking a decrease of 89.68.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.67. This value is within the healthy range. It has decreased from 4.59 (Mar 24) to 3.67, marking a decrease of 0.92.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 3. It has decreased from 2.87 (Mar 24) to 2.43, marking a decrease of 0.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9,804.24. It has decreased from 10,438.77 (Mar 24) to 9,804.24, marking a decrease of 634.53.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.82. This value exceeds the healthy maximum of 3. It has decreased from 7.08 (Mar 24) to 6.82, marking a decrease of 0.26.
- For EV / EBITDA (X), as of Mar 25, the value is 23.78. This value exceeds the healthy maximum of 15. It has decreased from 25.40 (Mar 24) to 23.78, marking a decrease of 1.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.83. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 5.83, marking a decrease of 0.64.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 83.28 (Mar 24) to 0.00, marking a decrease of 83.28.
- For Price / BV (X), as of Mar 25, the value is 2.94. This value is within the healthy range. It has decreased from 3.45 (Mar 24) to 2.94, marking a decrease of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.83. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 5.83, marking a decrease of 0.64.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Anupam Rasayan India Ltd:
- Net Profit Margin: 11.13%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.95% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.27% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.43
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 81 (Industry average Stock P/E: 47.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.46
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.13%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | 1101 to 1107, 11th Floor, Icon Rio, Behind Icon Business Centre, Surat Gujarat 395007 | investors@anupamrasayan.com http://www.anupamrasayan.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Kiran C Patel | Chairman & Non-Exe.Director |
| Mrs. Mona A Desai | Vice Chairman & Whole Time Dir |
| Mr. Anand S Desai | Managing Director |
| Dr. Anuj Hemantbhai Thakar | Whole Time Director |
| Dr. Namrata Dharmendra Jariwala | Independent Director |
| Mr. Vijay Kumar Batra | Independent Director |
| Mr. Vinesh Prabhakar Sadekar | Independent Director |
| Mr. Hetul Krishnakant Mehta | Independent Director |
FAQ
What is the intrinsic value of Anupam Rasayan India Ltd?
Anupam Rasayan India Ltd's intrinsic value (as of 05 November 2025) is 604.96 which is 43.72% lower the current market price of 1,075.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 12,239 Cr. market cap, FY2025-2026 high/low of 1,197/601, reserves of ₹2,740 Cr, and liabilities of 5,269 Cr.
What is the Market Cap of Anupam Rasayan India Ltd?
The Market Cap of Anupam Rasayan India Ltd is 12,239 Cr..
What is the current Stock Price of Anupam Rasayan India Ltd as on 05 November 2025?
The current stock price of Anupam Rasayan India Ltd as on 05 November 2025 is 1,075.
What is the High / Low of Anupam Rasayan India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Anupam Rasayan India Ltd stocks is 1,197/601.
What is the Stock P/E of Anupam Rasayan India Ltd?
The Stock P/E of Anupam Rasayan India Ltd is 81.0.
What is the Book Value of Anupam Rasayan India Ltd?
The Book Value of Anupam Rasayan India Ltd is 281.
What is the Dividend Yield of Anupam Rasayan India Ltd?
The Dividend Yield of Anupam Rasayan India Ltd is 0.07 %.
What is the ROCE of Anupam Rasayan India Ltd?
The ROCE of Anupam Rasayan India Ltd is 7.33 %.
What is the ROE of Anupam Rasayan India Ltd?
The ROE of Anupam Rasayan India Ltd is 3.32 %.
What is the Face Value of Anupam Rasayan India Ltd?
The Face Value of Anupam Rasayan India Ltd is 10.0.